| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0006805 | Xenobiotic metabolic process | Decreases phenotype | PMID:30545405 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:25461544 |
| GO:0008283 | Cell population proliferation | Affects phenotype | PMID:25461544 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:29137186; PMID:32822773 |
| GO:0015872 | Dopamine transport | Affects phenotype | PMID:29115391 |
| GO:0030521 | Androgen receptor signaling pathway | Increases phenotype | PMID:19368227 |
| GO:0033484 | Cellular nitric oxide homeostasis | Affects phenotype | PMID:27431321 |
| GO:0035641 | Locomotory exploration behavior | Decreases phenotype | PMID:34936186 |
| GO:0036269 | Swimming behavior | Decreases phenotype | PMID:34936186 |
| GO:0042053 | Regulation of dopamine metabolic process | Increases phenotype | PMID:29137186 |
| GO:0042416 | Dopamine biosynthetic process | Decreases phenotype | PMID:29115391 |
| GO:0042417 | Dopamine metabolic process | Increases phenotype | PMID:32822773; PMID:34936186 |
| GO:1904480 | Positive regulation of intestinal absorption | Increases phenotype | PMID:30545405 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.